[Exaggerated interaction claims. With esomeprazole the data corroborate safety].
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D016907:Adverse Drug Reaction Reporting Systems; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001562:Benzimidazoles / Q000009:adverse effects; D004347:Drug Interactions; D064098:Esomeprazole / Q000009:adverse effects*; D006801:Humans; D000077402:Pantoprazole; D017494:Proton Pumps / Q000187:drug effects*; D013454:Sulfoxides / Q000009:adverse effects
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D017494:Proton Pumps; D013454:Sulfoxides; D000077402:Pantoprazole; D064098:Esomeprazole